FDA.reportPublic FDA data

RELISTOR 150 MG Oral Tablet

RxCUI
1801519
RxNorm name
RELISTOR 150 MG Oral Tablet
Display name
RELISTOR 150 MG Oral Tablet
Full name
RELISTOR 150 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RelistorMETHYLNALTREXONE BROMIDESalix Pharmaceuticals, Inc.c488fb7c-0a5b-487c-b452-996809d1cb992024-05-01Warnings, Adverse reactionsExact identifier
rxcui: 1801519

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
c488fb7c-0a5b-487c-b452-996809d1cb99RELISTOR 150 MG Oral TabletPSN68These highlights do not include all the information needed to use RELISTOR safely and effectively. See full prescribing information for RELISTOR. RELISTOR ® (methylnaltrexone bromide) tablets, for oral use RELISTOR ® (methylnaltrexone bromide) injection, for subcutaneous use Initial U.S. Approval: 200820240501
c488fb7c-0a5b-487c-b452-996809d1cb99Relistor 150 MG (equivalent to methylnaltrexone 122.5 MG) Oral TabletSY68These highlights do not include all the information needed to use RELISTOR safely and effectively. See full prescribing information for RELISTOR. RELISTOR ® (methylnaltrexone bromide) tablets, for oral use RELISTOR ® (methylnaltrexone bromide) injection, for subcutaneous use Initial U.S. Approval: 200820240501
c488fb7c-0a5b-487c-b452-996809d1cb99methylnaltrexone bromide 150 MG Oral Tablet [Relistor]SBD68These highlights do not include all the information needed to use RELISTOR safely and effectively. See full prescribing information for RELISTOR. RELISTOR ® (methylnaltrexone bromide) tablets, for oral use RELISTOR ® (methylnaltrexone bromide) injection, for subcutaneous use Initial U.S. Approval: 200820240501